These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 24487967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations.
    Gao Y, Song P, Li H, Jia H, Zhang B.
    BMC Cancer; 2017 Jul 14; 17(1):484. PubMed ID: 28705152
    [Abstract] [Full Text] [Related]

  • 5. Analysis of CEA expression and EGFR mutation status in non-small cell lung cancers.
    Yang ZM, Ding XP, Pen L, Mei L, Liu T.
    Asian Pac J Cancer Prev; 2014 Jul 14; 15(8):3451-5. PubMed ID: 24870738
    [Abstract] [Full Text] [Related]

  • 6. Monitoring of carcinoembryonic antigen levels is predictive of EGFR mutations and efficacy of EGFR-TKI in patients with lung adenocarcinoma.
    Zhang Y, Jin B, Shao M, Dong Y, Lou Y, Huang A, Han B.
    Tumour Biol; 2014 May 14; 35(5):4921-8. PubMed ID: 24459065
    [Abstract] [Full Text] [Related]

  • 7. Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas.
    Shoji F, Yoshino I, Yano T, Kometani T, Ohba T, Kouso H, Takenaka T, Miura N, Okazaki H, Maehara Y.
    Cancer; 2007 Dec 15; 110(12):2793-8. PubMed ID: 17941001
    [Abstract] [Full Text] [Related]

  • 8. Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma.
    Li H, Wang Y, Su F, Li J, Gong P.
    Int J Clin Exp Pathol; 2015 Dec 15; 8(5):5577-83. PubMed ID: 26191267
    [Abstract] [Full Text] [Related]

  • 9. Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma.
    Ko KH, Hsu HH, Huang TW, Gao HW, Shen DH, Chang WC, Hsu YC, Chang TH, Chu CM, Ho CL, Chang H.
    Eur J Nucl Med Mol Imaging; 2014 Oct 15; 41(10):1889-97. PubMed ID: 24852187
    [Abstract] [Full Text] [Related]

  • 10. Genotype-phenotype correlation in Chinese patients with pulmonary mixed type adenocarcinoma: Relationship between histologic subtypes, TITF-1/SP-A expressions and EGFR mutations.
    Jie-Liu, Li XY, Zhao YQ, Liu RQ, Zhang JB, Ma J, Chen LJ, Hu XF.
    Pathol Res Pract; 2014 Mar 15; 210(3):176-81. PubMed ID: 24370340
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of serum EGFR gene mutation and serum tumor markers in predicting tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
    Feng LX, Wang J, Yu Z, Song SA, Zhai WX, Dong SH, Yu HS, Zhang Y.
    Clin Transl Oncol; 2019 Aug 15; 21(8):1005-1013. PubMed ID: 30637712
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma.
    Uysal M, Beypinar I, Araz M.
    J Cancer Res Ther; 2024 Apr 01; 20(3):909-912. PubMed ID: 38261436
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation between EGFR mutations and serum tumor markers in lung adenocarcinoma patients.
    Pan JB, Hou YH, Zhang GJ.
    Asian Pac J Cancer Prev; 2013 Apr 01; 14(2):695-700. PubMed ID: 23621221
    [Abstract] [Full Text] [Related]

  • 16. Associations between epidermal growth factor receptor gene mutation and serum tumor markers in advanced lung adenocarcinomas: a retrospective study.
    Pan YQ, Shi WW, Xu DP, Xu HH, Zhou MY, Yan WH.
    Chin Med Sci J; 2014 Sep 01; 29(3):156-61. PubMed ID: 25264883
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.
    Sun Y, Ren Y, Fang Z, Li C, Fang R, Gao B, Han X, Tian W, Pao W, Chen H, Ji H.
    J Clin Oncol; 2010 Oct 20; 28(30):4616-20. PubMed ID: 20855837
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.